Послать статью по эл. почте 
Внутрипеченочная холангиокарцинома
https://doi.org/10.20862/0042-4676-2015-0-1-52-63
Аннотация
Об авторах
А. Б. ЛукьянченкоРоссия
д. м. н., профессор, вед. науч. сотр. отдела лучевой диагностики и интервенционной радиологии
Б. М. Медведева
Россия
к. м. н., ст. науч. сотр. отдела лучевой диагностики и интервенционной радиологии;
М. А. Шабанов
Россия
д. м. н., профессор, вед. науч. сотр. патологоанатомического отделения
Э. Р. Виршке
Россия
д. м. н., вед. науч. сотр. отдела лучевой диагностики и интервенционной радиологии
В. В. Бредер
Россия
к. м. н., ст. науч. сотр. хирургического отделения клинических биотехнологий
К. А. Романова
Россия
аспирант
Список литературы
1. Ros P.R., Buck J.L., Goodman Z.D., Ros A.M.V., Olmsted W.W. Intrahepatic cholangiocarcinoma: radiologicpathologic correlation. Radiology. 1988; 167: 689–93.
2. Landis S.H., Murrey T., Bolden S., Wingo P.A. Cancer statistics 1998. Cancer J. Clin.1998; 48 (6): 6–29.
3. Cancer statistics in Russia and CIS in 2008. Vestnik Rossiyskogo onkologicheskogo nauchnogo tsentra imeni N.N. Blokhina Rossiyskoy akademii meditsinskikh nauk. 2010; 21 (2; Suppl. 1) (in Russian).
4. Sugihara S., Kojiro M. Pathology of cholangiocarcinoma. In: Nakashima T., Kojiro M. (eds). Hepatocellular carcinoma: an atlas of its pathology. Tokyo: Springer-verlag; 1987.
5. Stain S.C., Baer H.L.I., Dennison A.R., Blumgart L.H. Current management of hilar cholangiocarcinoma. Surg. Gynecol. Obstet. 1992; 1 (75): 579–88. 7. Ahrendt S.A., Pitt H.A. Biliary tract. In: Townsend C. (ed.) Sabiston Textbook of Surgery. Philadelphia: W.B. Saunders Company; 2001: 1076–111.
6. Nakanuma Y., Curado M.P., Franceschi S., Gores G., Paradis V., Sripa B. et al. Intrahepatic cholangiocarcinoma In: Bosman F.D., Carneiro F., Hruban R.H., Theise N.D. (eds). WHO Classification of Tumours of the Digestive System Lyon; 2010: 217–25.
7. Maetani Y., Itoh K., Watanabe C., Shibata T., Ametani F., Yamabe H. MR Imaging of Intrahepatic Cholangiocarcinoma with Pathologic Correlation. AJR. 2001; 176: 1499–507.
8. Shaib Y.H., El-Serag H.B., Nooka A.K., Thomas M., Brown T.D., Patt Y.Z. et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am. J. Gastroenterol. 2007; 102: 1016–21.
9. Welzel T.M., Graubard B.I., ElSerag H.B., Shaib Y.H., Hsing A.W., Davila J.A. et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin. Gastroenterol. Hepatol. 2007; 5: 1221–8.
10. De Oliveira M.L., Cunningham S.C., Cameron J.L., Kamangar F., Winter J.M., Lillemoe K.D. et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann. Surg. 2007; 245: 755–62.
11. Nakeeb A., Pitt H.A., Sohn T.A., Coleman J., Abrams R.A., Piantadosi S. et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann. Surg. 1996; 224: 463–73; discussion 473–5.
12. Khan S.A., Davidson B.R., Goldin R., Pereira S.P., Rosenberg W.M., Taylor- Robinson S.D. et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut. 2002; 51 (6): 1–9.
13. Soyer P., Bluemke D.A., Reichle R., Calhoun P.S., Bliss D.F., Scherrer A. et al. Imaging of Intrahepatic Cholangiocarcinoma: 1. Peripheral Cholangiocarcinoma. AJR. 1995; 165: 1427–31.
14. Chen L.D., Xu H.X., Xie X.Y., Lu M.D., Liu G.J., Liang J.Y. et al. Enhancement patterns of intrahepatic cholangiocarcinoma: comparison between contrast-enhanced ultrasound and contrast-enhanced CT. Brit. J. Radiol. 2008; 81: 881–9.
15. Choi B.I., Park J.H., Kim Y.I., Yu E.S., Kim S.H., Kim W.H. et al. Peripheral cholangiocarcinoma and clonorchiasis: CT findings. Radiology. 1988; 169: 149–53.
16. Soyer P., Bluemke D.A., Reichle R., Calhoun P.S., Bliss D.F., Scherrer A. et al. Imaging of intrahepatic cholangiocarcinoma: 2. Hilar cholangiocarcinoma. AJR.1995; 165: 1433–6.
17. Kim S.J., Lee J.M., Han J.K., Kim K.H., Lee J.Y., Choi B.I. Peripheral mass-forming cholangiocarcinoma in cirrhotic liver. AJR. 2007; 189: 1428–34.
18. Lacomis J.M., Baron R.L., Oliver J.H. 3rd., Nalesnik M.A., Federle M.P. Cholangiocarcinoma: delayed CT contrast enhancement patterns. Radiology. 1997; 203 (1): 98–104.
19. Chung Y.E., Kim M.J., Park Y.N., Choi J.Y., Pyo J.Y., Kim Y.C. et al. Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics. 2009; 29 (3): 683–700.
20. Kim S.A., Lee J.M., Lee K.B., Kim S.H., Yoon S.H., Han J.K. et al. Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern –correlation with clinicopathologic findings. Radiology. 2011; 260 (1): 148–57.
21. Soyer P., Bluemke D.A., Vissuzaine C., Beers B.V., Barge J., Levesque M. CT of hepatic tumors: prevalence and specificity of retraction of the adjacent capsule. AJR. 1994; 162: 1119–22.
22. Itai Y., Hachiya J., Makita K., Ohtomo K., Kokubo T., Yamauchi T. Transient hepatic attenuation differences on dynamic computed tomography. J. Comput. Assist. Tomogr. 1987; 11: 461–5.
23. Kim T.K., Choi B.I., Han J.K., Jang H.J., Cho S.G., Han M.C. Peripheral cholangiocarcinoma of the liver: two-phase spiral CT findings. Radiology. 1997; 204: 539–54.
24. Zhang Y., Uchida M., Abe T., Nishimura H., Hayabuchi N., Nakashima Y. Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI. J. Comput. Assist. Tomogr. 1999; 23: 670–7.
25. Kim H.J., Kim A.Y., Kim T.K., Byun J.H., Won H.J., Kim K.W. еt аl. Transient hepatic attenuation differences in focal hepatic lesions: dynamic CT features. AJR. 2005; 184: 83–90.
26. Feydy А., Vilgrain V., Denys A., Sibert A., Belghiti J., Vulliemre M.P. еt аl. Helical CT assessment in hilar cholangiocarcinoma: correlation with surgical and pathologic findings. AJR. 1999; 172: 73–7. 29. Kang Y., Lee J.M., Kim S.H., Han J.K., Choi B.I. Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images. Radiology. 2012; 264 (3): 751–60.
27. Manfredi R., Barbaro B., Masselli G., Vecchioli A., Marano P. Magnetic resonance imaging of cholangiocarcinoma. Semin. Liver. Dis. 2004; 24 (2): 155–64.
28. Vilgrain V., Van Beers B.E., Flejou J.F., Belghiti J., Delos M., Gautier A.L. et al. Intrahepatic cholangiocarcinoma: MRI and pathologic correlation in 14 patients. J. Comput. Assist. Tomogr. 1997; 21 (1): 59–65.
29. Kang Y., Lee J.M., Kim S.H., Han J.K., Choi B.I. Cholangiocarcinoma: enhancement patterns on gadoxetic acidenhanced MR images. Radiology. 2012; 264 (3): 751–60.
30. Loyer E.M., Chin H., DuBrow R.A., David C.L., Eftekhari F., Charnsangavej C. Hepatocellular carcinoma and intrahepatic peripheral cholangiocarcinoma: enhancement patterns with quadruple phase helical CT – a comparative study. Radiology. 1999; 212 (3): 866–75.
31. Lazaridis K.N., Gores G.J. Cholangiocarcinoma. Gastroenterology. 2005; 128: 1655–67.
32. Hochwald S.N., Burke E.C., JarnaginW. R., Fong Y., Blumgart L.H. Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma. Arch. Surg. 1999; 134: 261–6.
33. Clary B., Jarnigan W., Pitt H., Gores G., Busuttil R., Pappas T. Hilar cholangiocarcinoma. J. Gastrointest. Surg. 2004; 8 (3): 298–302.
34. Burke E.C., Jarnagin W.R., Hochwald S.N., Pisters P.W., Fong Y., Blumgart L.H. Hilar cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann. Surg. 1998; 228: 385–94.
35. Jarnagin W.R., Fong Y., DeMatteo R.P., Gonen M., Burke E.C., Bodniewicz B.S. et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann. Surg. 2001; 234: 507–17; discussion 517–9.
36. Patyutko Yu.I., Sagaydak I.V., Chuchuev E.S., Gakhramanov A.D., Ivanov A.A. Surgical resection of primary liver cancer. Prakticheskaya onkologiya. 2008; 9 (4): 197–201 (in Russian).
37. Chissov V.P., Dar'yalova S.L., Patyutko Yu.I., Sagaydak I.V., Kotel'nikov A.G. Liver Cancer. In: Oncology Guide. Moscow; 2008: 454–97 (in Russian).
38. Nakagohri T., Kinoshita T., Konishi M., Takahashi S., Gotohda N. Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma. World J. Surg. 2008; 32 (12): 2675–80. 42. Kondo S., Takada T., Miyazaki M., Miyakawa S., Tsukada K., Nagino M. et al. Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment. J. Hepatobiliary Pancreat Surg. 2008; 15: 41–54.
39. Morise Z., Sugioka A., Tokoro T., Tanahashi Y., Okabe Y., Kagawa T. et al. Surgery and chemotherapy for intrahepatic cholangiocarcinoma. Word J. Hepatol. 2010; 27; 2 (2): 58–64.
40. De Jong M.C., Nathan H., Sotiropoulos G.C., Paul A., Alexandrescu S., Marques H. et al. Intrahepatic cholangiocarcinoma: an international multiinstitutional analysis of prognostic factors and lymph node assessment. J. Clin. Oncol. 2011; 23 (10): 3140–5.
41. Eckel F., Schmid R.M. Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials. Brit. J. Cancer. 2007; 96: 896–902. 46. Eckel F., Brunner T., Jelic S. Biliary cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2011; 22 (6): vi40–vi44.
42. Valle J.W., Wasan H., Johnson P., Jones E., Dixon L., Swindell R. et al. Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study – The UK ABC-01 Study. Brit. J. Cancer. 2009; 101: 621–7.
Дополнительные файлы
Для цитирования: Лукьянченко А.Б., Медведева Б.М., Шабанов М.А., Виршке Э.Р., Бредер В.В., Романова К.А. Внутрипеченочная холангиокарцинома. Вестник рентгенологии и радиологии. 2015;(1):52-63. https://doi.org/10.20862/0042-4676-2015-0-1-52-63
For citation: Luk’yanchenko A.B., Medvedeva B.M., Shabanov M.A., Virshke E.R., Breder V.V., Romanova K.A. Intrahepatic cholangiocarcinoma. Journal of radiology and nuclear medicine. 2015;(1):52-63. (In Russ.) https://doi.org/10.20862/0042-4676-2015-0-1-52-63
Обратные ссылки
- Обратные ссылки не определены.